Population Based Assessment of Enterocystoplasty Complications in Adults

医学 外科 人口 队列 膀胱癌 回顾性队列研究 队列研究 比例危险模型 泌尿科 内科学 环境卫生 癌症
作者
Blayne K. Welk,Sender Herschorn,Calvin Law,Robert K. Nam
出处
期刊:The Journal of Urology [Lippincott Williams & Wilkins]
卷期号:188 (2): 464-469 被引量:31
标识
DOI:10.1016/j.juro.2012.04.013
摘要

PURPOSE: Enterocystoplasty can be used to treat several types of bladder dysfunction. We conducted a population based study to identify the rate and significant predictors of urological surgery after adult enterocystoplasty. MATERIALS AND METHODS: A retrospective, population based cohort was assembled using administrative data records, and adults who underwent enterocystoplasty between 1993 and 2009 were included in the analysis. Administrative data sources were used to measure primary exposure (neurogenic bladder and concurrent catheterizable channel or anti-incontinence procedure) and primary outcome (urological surgical procedures after enterocystoplasty). Multivariable Cox proportional hazards models were used (covariates of age, gender, Charlson score and socioeconomic status). RESULTS: We identified 243 patients, of whom 61% had a neurogenic bladder, 20% had a simultaneous incontinence procedure and 18% underwent creation of a catheterizable channel. Median followup was 7.8 years (IQR 4.0-12.2). The proportion of patients who required a subsequent urological procedure was 40% (0.098 procedures per person-year of followup). A simultaneous incontinence procedure at enterocystoplasty was a significant predictor of future surgical procedures (HR 1.47, 95% CI 1.02-2.12, p = 0.0414). Cystolitholapaxy was the most common subsequent procedure (25% of patients) and a catheterizable channel conferred a significant risk of cystolitholapaxy (HR 2.92, 95% CI 1.461-5.85, p = 0.0024). CONCLUSIONS: Repeat urological surgery is common after enterocystoplasty. Patients who require a simultaneous incontinence procedure at enterocystoplasty are more likely to require future surgery. Patients with catheterizable channels are at significant risk for future cystolitholapaxy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
温骐华完成签到 ,获得积分10
刚刚
缥缈月光完成签到,获得积分10
1秒前
共享精神的应助被敖烈采纳,获得10
1秒前
moose完成签到 ,获得积分10
1秒前
欢喜的乐安完成签到,获得积分10
1秒前
HaoruMeng发布了新的文献求助20
1秒前
2秒前
3秒前
寂寞的飞珍完成签到,获得积分10
3秒前
玛卡巴卡发布了新的文献求助10
4秒前
5秒前
乐乐的应助被Yanzhang0000采纳,获得10
5秒前
吗喽完成签到,获得积分10
6秒前
ZZ发布了新的文献求助10
6秒前
顾矜的应助被qqq采纳,获得10
6秒前
LEON发布了新的文献求助10
7秒前
7秒前
7秒前
嘀嘀嘀发布了新的文献求助10
8秒前
8秒前
完美世界的应助被zyy采纳,获得30
9秒前
DW的应助被Tang采纳,获得10
9秒前
弗洛伊德发布了新的文献求助10
9秒前
10秒前
XSJ关注了科研通微信公众号
10秒前
TJJJJJ完成签到,获得积分10
10秒前
流苏给流苏的求助进行了留言
11秒前
所所的应助被CITY111119采纳,获得10
11秒前
星辰大海的应助被礐嶨采纳,获得30
11秒前
老隋完成签到,获得积分10
11秒前
GWl完成签到,获得积分10
11秒前
Eric_Zhou完成签到,获得积分10
11秒前
专注的草丛完成签到,获得积分10
12秒前
12秒前
12秒前
清辉影的应助被MADAO采纳,获得30
12秒前
12秒前
清1完成签到,获得积分10
13秒前
傲骨完成签到 ,获得积分10
13秒前
lin完成签到 ,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181940
求助须知:如何正确求助?哪些是违规求助? 9571697
关于积分的说明 21819181
捐赠科研通 7778330
什么是DOI,文献DOI怎么找? 3433556
关于科研通互助平台的介绍 2557767
邀请新用户注册赠送积分活动 2479621